|
Market Closed -
Nasdaq
16:00:00 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 27.37 USD | +6.79% |
|
-15.91% | - |
| 08-25 | LifeSci Capital Initiates Coverage on Apnimed With Outperform Rating, $50 Price Target | MT |
| 08-25 | Cantor Fitzgerald Initiates Coverage on Apnimed With Overweight Rating, $60 Price Target | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
APMD 27.37 $
+6.79%
13.15M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| APMD | 27.37USD | +6.79% | 13.15M $ | |
CBOE
| APMD | 27.03USD | +4.85% | 345K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 32.55 | 32.55 | 31.75 |
| Spread/Res. | -15.91% | -15.91% | -13.80% |
| Spread/Supp. | +10.05% | +10.05% | +9.48% |
| Support | 24.87 | 24.87 | 25 |
- Stock Market
- Stocks
- APMD Stock
- Charts Apnimed, Inc.
Select your edition
All financial news and data tailored to specific country editions
